ATP6AP1 and Cognitive impairment: In humans, ATP6AP1 deficiency is associated to N- and O-glycosylation defects resulting in immunodeficiency hepatopathy and cognitive impairment in humans56, whilst clonal inactivating somatic mutations in ATP6AP1/A2 are found in the majority (>70%) of all granular cell tumors 57.